Intervention: DNA vaccine encoding IL-12Key results: Circulating PD-1+ CD4+ and CD8+ T cells declined with treatment; specific immune responses to gp100 were also detected and were correlated with an increase in CD8+, CD3+ T cells within the tumor. Here, CD8A is linked to neoplasm.